IASP Executive Committee Urges Venezuela to Focus on Access to Pain Medications in Light of Critical Shortages

Jul 18, 2017

The IASP Executive Committee adopted the following statement at its July meeting:

As the leading global organization that brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain with the goal of improved pain relief worldwide, the International Association for the Study of Pain (IASP) has been made aware that difficult conditions in Venezuela have resulted in inadequate access to pain treatment.

Dr. Martin Toro Ramírez, President of the Asociación Venezolana para el Estudio del Dolor (AVED), informs us that the country now lacks the medicines that are essential in treating acute and chronic pain, including cancer pain. In addition, the constituent presidents of the Latin American Federation of Associations for the Study of Pain (FEDELAT), a group composed of the Latin American chapters of our organization, have alerted us to the acute shortage of such medications.

We believe this situation requires urgent attention. In 2010, delegates to the International Pain Summit declared that “access to pain management is a fundamental human right” and that “all people with pain must have access to appropriate assessment and treatment of their pain by adequately trained health care professionals.”

IASP stands with our regional and local affiliates in support of patients and clinicians and strongly encourages the Venezuelan government to focus its attention on this critical situation and to move quickly to meet these needs of its people. 

IASP Executive Committee
Judith Turner, PhD, President
Lars Arendt-Nielsen, Dr. Med., PhD, President-Elect
Rolf-Detlef Treede, Dr. Med., Past President
Michael Nicholas, PhD, Secretary
G. Allen Finley, MD, FRCPC, Treasurer